Corbus Pharmaceuticals Holdings, Inc. SEC filings CRBP
Corbus Pharmaceuticals Holdings, Inc. has 808 filings in SEC EDGAR's recent list, going back to Jan 10, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 424B5 | Prospectus supplement | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 6, 2026 | Jul 2, 2026 |
| S-8 | Employee stock plan registration | Jun 17, 2026 | — |
| S-8 | Employee stock plan registration | May 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
May 21, 2026 | May 19, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 14, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 14, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Apr 7, 2026 | Apr 1, 2026 |
| ARS | Annual report to shareholders | Apr 2, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 2, 2026 | — |
| DEF 14A | Proxy statement | Apr 2, 2026 | Apr 1, 2026 |
| 424B3 | Prospectus | Mar 25, 2026 | — |
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 18, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 3, 2025 | Oct 30, 2025 |
| 424B5 | Prospectus supplement | Nov 3, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2025 | Oct 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
May 19, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 1, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 1, 2025 | — |
| DEF 14A | Proxy statement | Apr 1, 2025 | May 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 21, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 3, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Other events
|
Nov 15, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Aug 29, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 20, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2024 | Jun 1, 2024 |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Other events
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2024 | May 7, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2024 | Apr 10, 2024 |
| ARS | Annual report to shareholders | Apr 2, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 2, 2024 | — |
| DEF 14A | Proxy statement | Apr 2, 2024 | Mar 29, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2024 | May 16, 2024 |
| EFFECT | Filing | Mar 20, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 20, 2024 | Mar 20, 2024 |
| 10-K/A | Amended annual report | Mar 20, 2024 | Dec 31, 2023 |
| 424B3 | Prospectus | Mar 20, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2024 | — |
| S-3 | Shelf registration | Mar 13, 2024 | — |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 12, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 6, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K/A | Amended current report | Feb 2, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 1, 2024 | Jan 30, 2024 |
| 424B5 | Prospectus supplement | Feb 1, 2024 | — |
| S-3MEF | Filing | Jan 31, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 31, 2024 | Jan 30, 2024 |
| 424B5 | Prospectus supplement | Jan 31, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| 424B3 | Prospectus | Jan 29, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 26, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure, Other events
|
Jan 9, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
Nov 13, 2023 | Nov 10, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2023 | Nov 7, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Other events
|
Aug 3, 2023 | Aug 3, 2023 |
| EFFECT | Filing | Jun 13, 2023 | — |
| 424B3 | Prospectus | Jun 13, 2023 | — |
| S-3/A | Filing | Jun 12, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| S-3 | Shelf registration | Jun 1, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 24, 2023 | Mar 3, 2023 |
| DEF 14A | Proxy statement | Apr 3, 2023 | — |
| ARS | Annual report to shareholders | Apr 3, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 3, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2023 | — |
| 10-K | Annual report | Mar 7, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Mar 7, 2023 | Mar 3, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 6, 2023 | Mar 1, 2023 |
| 8-K/A |
Amended current report
Change to shareholder rights
|
Feb 15, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Feb 13, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
Jan 6, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Dec 21, 2022 | Dec 20, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Dec 21, 2022 | Nov 8, 2022 |
| DEF 14A | Proxy statement | Nov 14, 2022 | Dec 20, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 4, 2022 | Dec 20, 2022 |
| 8-K |
Current report
Material agreement
|
Oct 31, 2022 | Oct 25, 2022 |
| 8-A12G | Filing | Oct 12, 2022 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 12, 2022 | Oct 11, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 26, 2022 | Sep 20, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Listing notice, Other events
|
Jul 7, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Other events
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2022 | May 18, 2022 |
| 8-K |
Current report
Other events
|
May 17, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 11, 2022 | Apr 8, 2022 |
| DEFA14A | Additional proxy material | Apr 1, 2022 | — |
| DEF 14A | Proxy statement | Apr 1, 2022 | May 18, 2022 |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| 10-K | Annual report | Mar 8, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 8, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Listing notice
|
Jan 3, 2022 | Jan 3, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2021 | Sep 24, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 22, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 18, 2021 | Aug 16, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Other events
|
Jul 22, 2021 | Jul 22, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 24, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jun 1, 2021 | May 25, 2021 |
| DEFA14A | Additional proxy material | May 19, 2021 | — |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2021 | May 13, 2021 |
| DEFA14A | Additional proxy material | Apr 6, 2021 | — |
| DEF 14A | Proxy statement | Apr 6, 2021 | Apr 6, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 26, 2021 | Mar 26, 2021 |
| S-8 | Employee stock plan registration | Mar 16, 2021 | — |
| 10-K | Annual report | Mar 15, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 15, 2021 | Mar 14, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 4, 2021 | Feb 2, 2021 |
| 8-K |
Current report
Other events
|
Jan 27, 2021 | Jan 27, 2021 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 4, 2020 | Oct 8, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2020 | Nov 16, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 10, 2020 | Nov 10, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
|
Oct 8, 2020 | Oct 8, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 6, 2020 | Oct 6, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2020 | Sep 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2020 | Sep 11, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2020 | Sep 8, 2020 |
| 10-Q/A | Amended quarterly report | Aug 31, 2020 | Jun 30, 2020 |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 29, 2020 | Jul 28, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 8, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2020 | May 20, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 11, 2020 | May 11, 2020 |
| 424B3 | Prospectus | May 4, 2020 | — |
| EFFECT | Filing | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 30, 2020 | — |
| CORRESP | Letter to the SEC | Apr 24, 2020 | — |
| S-3/A | Filing | Apr 24, 2020 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 21, 2020 | Mar 30, 2020 |
| UPLOAD | Letter from the SEC | Apr 13, 2020 | — |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEF 14A | Proxy statement | Apr 9, 2020 | Apr 9, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 7, 2020 | Apr 7, 2020 |
| S-3 | Shelf registration | Apr 7, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRBP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Norwood, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595097
- Former names
- SAV Acquisition Corp (until Jan 10, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.